Tag Archives: ulcerative colitis

A Short IBD Survey

I’d like your help. As you probably are aware, this is a very personal website and much of the content focuses on living with (and living in spite of) Crohn’s disease and ulcerative colitis. I strive to share success stories and … Read the rest of this entry

Posted in Articles, Crohn's Disease | Tagged , , , | Leave a comment

The Double Date Adventure

It all started innocently enough with a charity auction. It ended this past Sunday when I was kidnapped by an evil pharmaceutical company, rescued by two women who then were poisoned by the pharmaceutical company’s CEO, and finally tagged along … Read the rest of this entry

Posted in Articles, Crohn's Disease, Innovation/Creativity, Marketing | Tagged , , , , , , | Leave a comment

Help Team Challenge cross the finish line in Sonoma

The Napa-to-Sonoma half marathon is less than three weeks away, and Team Challenge needs your help! If your donations help all seven people I’m mentoring meet their fundraising goal before 11:00 PM Central Time on Tuesday, July 6, 2010, I will publicly shave my head following the 2010 Napa-to-Sonoma half marathon. Read the rest of this entry

Posted in Crohn's Disease | Tagged , , , , , | Leave a comment

Is generic Remicade (Humira, etc.) in our future?

As part of $3K in 3 Weeks, here is another in a series of articles on current issues and topics related to Crohn’s disease and ulcerative colitis. Did you know that biologics1 such as Remicade, Humira, and Cimzia – used … Read the rest of this entry

Posted in $3K in 3 Weeks, Crohn's Disease, Science | Tagged , , , , , , , , , , | Leave a comment

Research Update: The Human Gut Microbiome Initiative

As part of $3K in 3 Weeks, here is the first in a series of articles on current research initiatives related to Crohn’s disease and ulcerative colitis. The Human Gut Microbiome Initiative, based at the Genome Center of Washington University … Read the rest of this entry

Posted in $3K in 3 Weeks, Crohn's Disease | Tagged , , , , , , , , | Leave a comment